XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 109.40%151.96M | ---- | -814.04%-1.62B | ---- | -282.38%-176.85M | ---- | -208.04%-65.32M | -7.58%96.97M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -1,283.02%-68.6M | ---- | -780.99%-4.96M | ---- | -1,555.88%-563K | ---- | -71.43%-12K | -142.86%-34K | ---- |
Impairment and provisions: | ---- | -98.41%11.34M | ---- | 6,389.80%712.91M | ---- | --10.99M | ---- | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | -98.41%11.34M | ---- | 6,389.80%712.91M | ---- | --10.99M | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | --207.67M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | --207.67M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -61.32%199.58M | ---- | 70.35%515.94M | ---- | 120.57%302.86M | ---- | 78.17%50.03M | 94.46%137.31M | ---- |
-Amortization of intangible assets | ---- | 0.00%17K | ---- | 0.00%17K | ---- | 0.00%17K | ---- | 0.00%4K | 0.00%17K | ---- |
Financial expense | ---- | -33.82%27.8M | ---- | -27.18%42.01M | ---- | 101.30%57.69M | ---- | 77.03%11.82M | 74.98%28.66M | ---- |
Special items | ---- | -91.94%46.31M | ---- | 530.15%574.7M | ---- | 960.61%91.2M | ---- | 1,874.22%91.32M | ---10.6M | ---- |
Operating profit before the change of operating capital | ---- | 64.38%368.39M | ---- | -54.54%224.11M | ---- | 95.40%492.99M | ---- | 946.25%87.83M | 31.48%252.31M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -38.35%15.75M | ---- | 203.62%25.54M | ---- | -83.25%-24.65M | ---- | -110.87%-305K | 16.59%-13.45M | ---- |
Accounts receivable (increase)decrease | ---- | ---47.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts payable increase (decrease) | ---- | -56.10%-65.38M | ---- | -181.85%-41.88M | ---- | 4.12%51.17M | ---- | -51.19%10.97M | 5,139.13%49.14M | ---- |
prepayments (increase)decrease | ---- | 84.68%-7.72M | ---- | 43.13%-50.4M | ---- | -518.89%-88.63M | ---- | ---- | ---14.32M | ---- |
Special items for working capital changes | ---- | --9.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from business operations | -82.24%38.63M | 73.02%272.28M | 207.98%217.58M | -63.48%157.37M | -51.17%70.65M | 57.44%430.89M | 203.85%144.68M | 192.52%98.5M | 54.88%273.68M | --47.62M |
Other taxs | 136.94%639K | 118.92%2.74M | 87.49%-1.73M | 77.47%-14.49M | 63.97%-13.83M | -131.10%-64.3M | -5,003.72%-38.38M | -26.61%-12.9M | -57.34%-27.82M | ---752K |
Net cash from operations | -81.81%39.27M | 92.47%275.02M | 279.90%215.85M | -61.02%142.89M | -46.55%56.82M | 49.11%366.59M | 126.83%106.3M | 264.51%85.6M | 54.60%245.85M | --46.87M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 33.06%35.5M | 1,054.78%57.28M | 2,904.05%26.68M | 780.99%4.96M | 3,315.38%888K | 1,555.88%563K | 85.71%26K | 71.43%12K | 142.86%34K | --14K |
Decrease in deposits (increase) | 69.06%-132.34M | -123.27%-450.04M | ---427.71M | ---201.57M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | --14.04M | -73.51%2.7M | ---- | --10.2M | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | 61.38%-5.78M | 87.73%-45.55M | 93.20%-14.96M | 62.64%-371.16M | -8.63%-219.89M | -835.77%-993.52M | -1,063.34%-202.43M | -970.63%-95.4M | -40.07%-106.17M | ---17.4M |
Other items in the investment business | ---- | ---1.54M | ---1.54M | ---- | ---- | 69.76%-1.13M | ---1.13M | -68.15%-1.13M | 66.50%-3.74M | ---- |
Net cash from investment operations | 78.79%-88.58M | 21.60%-437.16M | -90.65%-417.54M | 43.91%-557.57M | -7.60%-219.01M | -804.75%-994.09M | -1,070.63%-203.54M | -907.96%-96.52M | -26.23%-109.87M | ---17.39M |
Net cash before financing | 75.55%-49.31M | 60.90%-162.14M | -24.36%-201.69M | 33.91%-414.68M | -66.80%-162.19M | -561.46%-627.5M | -429.86%-97.24M | -178.56%-10.93M | 88.91%135.98M | --29.48M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | 1,381.25%237M | 450.00%55M | --30M | 23.94%16M | --10M |
Refund | ---- | ---- | ---- | ---- | ---- | -2,189.33%-285.14M | -708.33%-48.14M | -708.33%-48.14M | ---12.46M | ---5.96M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --2.75B | --213.05M | --212.29M | ---- | ---- |
Interest paid - financing | 64.94%-6.11M | 33.82%-27.8M | 53.02%-17.43M | 27.18%-42.01M | -41.59%-37.1M | -101.30%-57.69M | -106.97%-26.21M | -77.03%-11.82M | -74.98%-28.66M | ---12.66M |
Dividends paid - financing | ---397.47M | ---146.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---3.68M | ---6.61M | ---- | ---- | ---- | -9,590.72%-97.1M | ---1.51M | ---1.51M | ---1M | ---- |
Other items of the financing business | --166K | ---1.71M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -294.29%-448.54M | -46.74%-323.15M | 38.70%-113.76M | -109.84%-220.21M | -287.99%-185.57M | 1,769.50%2.24B | 386.81%98.71M | 508.43%136.89M | -124.46%-134M | ---34.42M |
Effect of rate | -46.34%20.96M | -86.78%13.9M | -37.83%39.06M | 1,556.94%105.16M | 12,466.40%62.83M | -32,909.09%-7.22M | 137.04%500K | 1,866.42%2.64M | 450.00%22K | ---1.35M |
Net Cash | -57.82%-497.85M | 23.56%-485.29M | 9.29%-315.45M | -139.44%-634.9M | -23,692.47%-347.75M | 81,362.25%1.61B | 129.85%1.47M | 742.37%125.97M | -83.91%1.98M | ---4.94M |
Begining period cash | -42.97%625.61M | -32.56%1.1B | -32.56%1.1B | 6,606.79%1.63B | 6,606.79%1.63B | 8.98%24.26M | 8.98%24.26M | 8.98%24.26M | 123.19%22.26M | --22.26M |
Cash at the end | -81.88%148.72M | -42.97%625.61M | -38.84%820.61M | -32.56%1.1B | 5,015.75%1.34B | 6,606.79%1.63B | 64.25%26.23M | 5,396.51%152.86M | 8.98%24.26M | --15.97M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.